Elucidation of the molecular mechanism of action of psychoactive substances as novel antidepressants
According to the World Health Organization (WHO) depression is the leading cause of disability worldwide with more than 300 million patients affected. Current antidepressants have a delayed onset of action and moreover, only two-thirds of patients suffering from depressive disorder respond to antide...
Main Author: | Großert, Alessandra |
---|---|
Other Authors: | Prof. Dr. Nicole Teusch |
Format: | Doctoral Thesis |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://repositorium.ub.uni-osnabrueck.de/handle/urn:nbn:de:gbv:700-202003312713 |
Similar Items
-
Ketamine Increases Proliferation of Human iPSC-Derived Neuronal Progenitor Cells via Insulin-Like Growth Factor 2 and Independent of the NMDA Receptor
by: Alessandra Grossert, et al.
Published: (2019-09-01) -
Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
by: Sherida de Leeuw, et al.
Published: (2019-07-01) -
Neuroplasticity and the next wave of antidepressant strategies.
by: Shawn eHayley, et al.
Published: (2013-11-01) -
Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic Acidemia
by: Esmeralda Alonso-Barroso, et al.
Published: (2021-01-01) -
Familial Alzheimer’s Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis
by: Charles Arber, et al.
Published: (2021-01-01)